Skip to main content
placeholder image

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

Journal Article


Abstract


  • Background

    Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19.

    Methods

    A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Embase and PubMed were searched for relevant studies.

    Results

    A total of six studies with 1527 patients were included in this analysis. The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively. The incidences of hypertension, cardia-cerebrovascular diseases and diabetes were about twofolds, threefolds and twofolds, respectively, higher in ICU/severe cases than in their non-ICU/severe counterparts. At least 8.0% patients with COVID-19 suffered the acute cardiac injury. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients.

    Conclusion

    Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart.

Publication Date


  • 2020

Citation


  • Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., . . . Zhao, Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.. Clinical research in cardiology : official journal of the German Cardiac Society, 109(5), 531-538. doi:10.1007/s00392-020-01626-9

Web Of Science Accession Number


Start Page


  • 531

End Page


  • 538

Volume


  • 109

Issue


  • 5

Abstract


  • Background

    Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19.

    Methods

    A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Embase and PubMed were searched for relevant studies.

    Results

    A total of six studies with 1527 patients were included in this analysis. The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively. The incidences of hypertension, cardia-cerebrovascular diseases and diabetes were about twofolds, threefolds and twofolds, respectively, higher in ICU/severe cases than in their non-ICU/severe counterparts. At least 8.0% patients with COVID-19 suffered the acute cardiac injury. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients.

    Conclusion

    Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart.

Publication Date


  • 2020

Citation


  • Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., . . . Zhao, Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.. Clinical research in cardiology : official journal of the German Cardiac Society, 109(5), 531-538. doi:10.1007/s00392-020-01626-9

Web Of Science Accession Number


Start Page


  • 531

End Page


  • 538

Volume


  • 109

Issue


  • 5